Current Hematologic Malignancy Reports
Last updated ISSN 1558-8211
Current Hematologic Malignancy Reports is published by Springer Science+Business Media in medicine. It is a subscription journal. The article processing charge is $3,790.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Current Hematologic Malignancy Reports is — and show you journals like it.
What it publishes
Recent work in Current Hematologic Malignancy Reports concentrates on these topics, taken from its published record rather than from its own description:
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CAR-T cell therapy research
- Multiple Myeloma Research and Treatments
- Eosinophilic Disorders and Syndromes
- Hematopoietic Stem Cell Transplantation
Key facts
| Publisher | Springer Science+Business Media |
|---|---|
| ISSN | 1558-8211, 1558-822X |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | $3,790 |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 890 |
| Publishing since | 1975 |
| Journal website | www.springer.com/journal/11899 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Current Hematologic Malignancy Reports
Other established journals in medicine, if this one is not the right home for your paper: